Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed attachment file name title grouped question UIN question first answered answering member label
tabling member	label

Search

529943

registered interest
date	29/06/2016
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Stamp Duty Land Tax
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answer by Baroness Altmann on 16 June (HL502), what provision is made for claimants suffering severe myalgic encephalomyelitis or chronic fatigue syndrome who are housebound or bedbound and who are unable to attend a face-to-face consultation.
tabling member printed	The Countess of Mar
uin	HL871
answer	answer is ministerial correction date of answer 13/07/2016 answer text <p>A home consultation can be offered where a claimant is unable to travel to a consultation as a result of their health condition or impairment.</p><p> </p><p>Situations where a claimant may need a home consultation can include where a person’s diagnosis suggests a significant disability that may make travel extremely difficult or the claimant provides evidence from a health professional that they are unable to travel due to their health condition or impairment.</p> answering member printed Baroness Altmann question first answered 13/07/2016 15:08:42 answering member 4533 label Biography information for Baroness Altmann
tabling member	1861 label Biography information for The Countess of Mar

1131898

registered interest
date	12/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	International Life Sciences Institute
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, following the publication of the study on the International Life Sciences Institute "Are industry-funded charities promoting “advocacy-led studies” or “evidence-based science”?, whether they classify the International Life Sciences Institute as an industry lobby group or a scientific health charity.
tabling member printed	The Countess of Mar
uin	HL16316
answer	answer is ministerial correction date of answer 26/06/2019 answer text <p>The Department funds research via the National Institute for Health Research (NIHR). The NIHR does not itself classify any organisation in terms of charitable status or lobby group. The NIHR regards a charity as a specific type of voluntary organisation which must conform to the regulations set out in charity law particularly the Charities Act 2011. Charity is a legal status for an organisation, not a legal form or organisational structure.</p><p>Any organisation which considers that it can carry out high-quality clinical, applied health or social care research is likely to be eligible for Departmental, NIHR-funded research programmes, either directly or with a partner. There are specific guidance documents setting out eligibility criteria for the NIHR’s programmes which include information on partnership working, funding mechanism and contractual obligations including reporting and disclosure of conflicts of interest.</p> answering member printed Baroness Barran question first answered 26/06/2019 13:13:51 answering member 4703 label Biography information for Baroness Barran
tabling member	1861 label Biography information for The Countess of Mar

1128009

registered interest
date	21/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Children
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what processes are in place to safeguard children with chronic fatigue syndrome and other disorders whose parents have enrolled them on Lightning Process courses; and what evaluation has been undertaken of the (1) benefits, and (2) harms, to those children who have participated in such courses.
tabling member printed	The Countess of Mar
uin	HL15894
answer	answer is ministerial correction date of answer 05/06/2019 answer text <p>The Lightning Process (LP) is not offered as a part of the chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) standard treatments on the National Health Service. Subject to the nature of the safeguarding concerns, issues should be directed to the relevant professional regulator, should the practitioner be a member of a registered profession; the local authority (trading standards office or children’s service), if false claims are being made about the effectiveness of the treatment or welfare of a child is a concern; or the police, if a crime is involved.</p><p>The LP involves a course of three half-days of training aiming to teach participants how to use their brain to improve their body's health.</p><p>A randomised controlled trial with 100 adolescents aged 12-18 was undertaken by researchers in Bristol. Participants were randomised into two groups: those who received standard CFS/ME treatment and those who received the standard treatment plus the LP.</p><p>Researchers found those who received the LP had better physical function, were less tired and less anxious after six months. At 12 months, they had further improvement in physical function, and improved depression scores and school attendance. This research trial had several limitations as set out in the peer reviewed journal article. This was a very small trial and so it would need to be repeated in a much larger group to demonstrate more generalisable findings. Participants were not blinded so their self-reported outcomes might have been biased, for example participants may have been more likely to report positive outcomes because they knew they were getting additional therapy in the LP group. Of all those eligible to participate in the trial, fewer than 30% agreed to take part. Participants in the trial did not have any serious adverse events attributable to either LP or usual care. LP therapy was given in addition to the usual CFS/ME care as a no-treatment control group was not deemed ethical, therefore it cannot be suggested as a replacement for current specialised medical care.</p><p>Independent ethical review ensures that participant safety is at the centre of all research. In the United Kingdom, review by an ethics committee is one of a series of safeguards intended to protect the people taking part in the research. The operating procedure for trials in the UK has inbuilt safeguards designed to protect patients from harm in the event an intervention is ineffective or potentially harmful. Participants are free to withdraw from a study at any time.</p><p> </p> answering member printed Baroness Blackwood of North Oxford question first answered 05/06/2019 16:40:17 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1861 label Biography information for The Countess of Mar

1131897

registered interest
date	12/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Food Standards Agency: Public Appointments
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government when they intend to approve the appointment of a Chief Executive for the Food Standards Agency; and what has been the cause of the delay.
tabling member printed	The Countess of Mar
uin	HL16315
answer	answer is ministerial correction date of answer 26/06/2019 answer text <p>The appointment is subject to the approval process which governs the Civil Service Commission Recruitment Principles. An announcement will be made once that process has concluded.</p> answering member printed Baroness Blackwood of North Oxford question first answered 26/06/2019 12:11:36 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1861 label Biography information for The Countess of Mar

1135740

registered interest
date	01/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they will place a copy of the World Health Organisation Global Advisory Committee on Vaccine Safety 2019 review of HPV vaccine safety in the Library of the House.
tabling member printed	The Countess of Mar
uin	HL16833
answer	answer is ministerial correction date of answer 15/07/2019 answer text <p>A meeting was held by the Global Advisory Committee on Vaccine Safety (GACVS) on 5 to 6 June 2019. However, the Medicines and Healthcare products Regulatory Agency is not aware of any formal review of human papillomavirus vaccine safety published by GACVS in 2019.</p> answering member printed Baroness Blackwood of North Oxford question first answered 15/07/2019 10:24:58 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1861 label Biography information for The Countess of Mar

1135741

registered interest
date	01/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mefloquine
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the European Medicines Agency Pharmacovigilance Risk Assessment Committee’s 2014 report on the toxicity of mefloquine (Larium).
tabling member printed	The Countess of Mar
uin	HL16834
answer	answer is ministerial correction date of answer 10/07/2019 answer text <p>At its meeting in February 2014, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency recommended that the product information for mefloquine (Lariam) be amended to state that neuropsychiatric adverse reactions may persist for months, or longer, even after discontinuation of the drug. The Medicines and Healthcare products Regulatory Agency (MHRA) accepted the recommendations and implemented the advice of the PRAC, which is reflected in the United Kingdom product information for mefloquine. In addition, the MHRA has since taken further action to ensure that these risks are adequately conveyed to UK prescribers and patients in the form of improved checklists for healthcare professionals and a patient alert card.</p> answering member printed Baroness Blackwood of North Oxford question first answered 10/07/2019 15:26:45 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1861 label Biography information for The Countess of Mar

1135743

registered interest
date	01/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mattresses: Fire Resistant Materials
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the risks to the neurological development of (1) foetuses, and (2) new-born children, of exposure to polyurethane mattresses treated with chlorinated phosphate flame retardants.
tabling member printed	The Countess of Mar
uin	HL16836
answer	answer is ministerial correction date of answer 15/07/2019 answer text <p>The Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment has considered the evidence on the potential effects of chlorinated and non-chlorinated phosphate flame retardants from all exposure sources, in general. The Committee is preparing a statement on phosphate-based flame retardants and the potential for neurodevelopmental toxicity. It is expected that the statement will be published in summer 2019.</p><p>Chlorinated organophosphorous flame retardants are regulated under the European Union REACH (Restriction, Evaluation, Authorisation and Restriction of Chemicals) regime. The United Kingdom has been proactive in supporting the regulation of flame retardants through REACH. The European Chemicals Agency has announced an intention to restrict a number of chlorinated flame retardants. It is expected that the restriction proposal will be submitted in July 2019, followed by a public consultation.</p><p> </p> answering member printed Baroness Blackwood of North Oxford question first answered 15/07/2019 10:24:38 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1861 label Biography information for The Countess of Mar

749951

registered interest
date	10/07/2017
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	NHS: Listed Buildings
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government whether the Health and Safety Executive will send a representative to the International Aircraft Cabin Air Conference at Imperial College, London in September; and if not, why not.
tabling member printed	The Countess of Mar
uin	HL636
answer	answer is ministerial correction date of answer 18/07/2017 answer text <p>The Health and Safety Executive (HSE) will not be attending the International Aircraft Cabin Air Conference at Imperial College, London in September 2017. HSE works with the Civil Aviation Authority (CAA) to regulate health and safety at work in the aviation industry. This operates through a memorandum of understanding and associated guidance document CAP 1484 (see documents attached).</p><p>CAP 1484 states that by agreement CAA regulates health and safety on board aircraft and advises on the health implications of exposure to hazardous substances on crew and passengers. CAA is the most appropriate regulatory attendee and HSE will seek information and updates on such issues through its regular contacts with CAA.</p> answering member printed Baroness Buscombe attachment 1 file name HL636 - Associated Guidance Document CAP 1484 (March 2017).pdf title Associated Guidance Document CAP 1484 2 file name HL636 - HSE CAA Memorandum of Understanding.pdf title HSE CAA Memorandum of Understanding question first answered 18/07/2017 13:18:23 answering member 3349 label Biography information for Baroness Buscombe
tabling member	1861 label Biography information for The Countess of Mar

1140485

registered interest
date	18/07/2019
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Social Security Benefits: Medical Examinations
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what controls and penalties are in place to ensure that providers of medical assessors for social security benefits maintain high standards of accuracy and integrity; and on how many occasions any such controls or penalties have been used since June 2018.
tabling member printed	The Countess of Mar
uin	HL17318
answer	answer is ministerial correction date of answer 12/08/2019 answer text <p>The department is committed to ensuring claimants receive high quality assessments. We set our assessment providers challenging targets and monitor performance closely against a range of measures including through independent audit to improve accuracy and decision making. Contractual remedies are in place if assessment providers fail to deliver against the service standards.</p><p>Contractual remedies for underperformance against a range of service levels are recovered through service credit mechanisms and through deductions of payments (a ‘No Pay’ mechanism). The extent of underperformance and application of related mechanisms varies significantly and the regularity of such remedies should not be seen as a measure of overall performance.</p><p>In relation to the HDAS contract covering Work Capability Assessments, service credits (the contractual remedy for SC1 – Quality) have been applied in 12 out of the 14 months from June 2018 to July 2019 (the date of the most recent statistical information available).</p><p>In relation to the Personal Independence Payment contracts, “No Pay” (the contractual remedy for SC1 – Quality) has been applied in one or more Lots in each month from June 18 to June 19 (the date of the most recent statistical information available).</p><p>Below is the breakdown of the totals by Lot:</p><p>Lot 1 – No pay was applied to SC1 in 8 of those months</p><p>Lot 2 – No pay was applied to SC1 in 5 of those months</p><p>Lot 3 – No pay was applied to SC1 in 11 of those months.</p> answering member printed Baroness Stedman-Scott question first answered 12/08/2019 15:58:29 answering member 4174 label Biography information for Baroness Stedman-Scott
tabling member	1861 label Biography information for The Countess of Mar

746633

registered interest
date	29/06/2017
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government what measures they are taking to ensure that flame retardant materials used in homes, offices and public spaces both (1) prevent fires, and (2) are non-toxic, (a) in normal use, (b) during fires, and (c) for disposal or recycling at the end of life of items, such as furniture, foam mattresses, electronic goods and building insulation which contain such materials.
tabling member printed	The Countess of Mar
uin	HL264
answer	answer is ministerial correction date of answer 13/07/2017 answer text <p>Public safety is a priority for Government. There are a range of measures in place across a number of Government departments to ensure the effectiveness and safety of flame retardant materials.</p><p> </p><p>The Department for Business, Energy and Industrial Strategy is responsible for product safety legislation, which requires products to be safe when they are placed on the market.</p><p> </p><p>The Department for the Environment, Food and Rural Affairs has responsibility for ensuring the safety of chemicals, including those used as flame retardants.</p><p> </p><p>The Health and Safety Executive oversees the EU regulations concerning the Registration, Evaluation, Authorisation and restriction of Chemicals (known as REACH). This has several aims, including providing a high level of protection of human health and the environment from the use of chemicals.</p><p> </p><p>Lead responsibility for the safety and effectiveness of flame retardant chemicals will rest with the Department responsible for any legislation specifying their usage.</p> answering member printed Baroness Williams of Trafford grouped question UIN HL265 question first answered 13/07/2017 14:40:39 answering member 4311 label Biography information for Baroness Williams of Trafford
tabling member	1861 label Biography information for The Countess of Mar